Assessment of Radial Artery Patency Following Catheterization With a 7F Sheath

December 26, 2012 updated by: Jaffe, Ronen, M.D.

Observational Study of Radial Artery Patency Following Catheterization With a 7F Sheath

Radial artery occlusion may occur after performance of coronary catheterization via the radial artery (transradial approach). In some cases it may be desirable to insert large (7F) catheters via the radial artery, however the impact of increased catheter size on subsequent radial artery patency is unclear. We hypothesize that radial artery occlusion following 7F catheterization is rare and occurs in < 5% of the cases.

Study Overview

Status

Unknown

Detailed Description

Background:

Coronary catheterization is a commonly performed diagnostic and therapeutic procedure. The procedure is most commonly performed via the transfemoral approach (via the femoral artery). Recently the transradial approach (via the radial artery) has been gaining popularity since it is associated with decreased risk of bleeding and facilitates patient mobilization following the procedure (1-3). During the catheterization procedure a sheath (tube) is inserted into the access artery so as to enable insertion of catheters and devices into the body. Vascular sheaths may have different internal diameters, which are measured in French (F) units. Commonly used sheath sizes for coronary catheterization are 5F and 6F, however use of larger 7F sheaths is beneficial when more complex procedures are performed such as insertion of two coronary stents. Use of a 7F sheath creates a slightly larger orifice within the blood vessel wall and may potentially increase the risk of damage to the vessel wall and hemorrhage.

The palm of the hand normally receives dual blood supply via the radial and ulnar arteries. Prior to performing transradial catheterization the ability of the ulnar artery to supply blood to the whole palm is confirmed by performing an Allen Test, in order to avoid palmar ischemia if the radial artery becomes occluded following the procedure. Radial artery occlusion in the presence of a normal pre-procedural Allen Test is almost universally asymptomatic, however it may preclude future use of the radial artery for vascular access or as a coronary graft if bypass surgery is performed. The frequency of radial artery occlusion following transradial catheterization ranges from 5% to 15% in different reports (4), depending on many factors such patient selection, degree of anticoagulation during the procedure and the time interval between performance of the procedure and studying the radial artery patency. Use of larger sheaths has also been reported as a risk factor for radial artery occlusion (5), however the true incidence of this complication is unclear. It is desirable to discover the true rate of radial artery occlusion following catheterization with a 7F sheath, since such knowledge may assist physicians in planning the optimal catheterization strategy.

Aims:

The aim of the study will be to examine the occurrence of radial artery occlusion following transradial catheterization with a 7F sheath.

Hypothesis:

Radial artery occlusion following 7F catheterization is rare and occurs in < 5% of the cases.

Methods:

The study will be performed as part of Mr. Dan Levin's required Medical School Thesis research at the Faculty of Medicine, Technion IIT, Haifa, Israel. Two-hundred subjects who have previously undergone transradial catheterization between the years 1999 and 2012 with a 7F sheath will be identified in the Lady Davis Carmel Medical Center Catheterization laboratory computerized database. The subjects will be contacted by the study investigators and will be invited to a meeting with the investigators at Carmel Medical Center. The study protocol consists of a single meeting between the investigators and the study subjects. During this meeting the subjects will be given explanation of the study protocol. If they consent to participate in the study they will sign an informed consent form, undergo physical examination of the reverse Allen test and ultrasound examination of the patency of the radial artery. Radial artery patency will be studied with the reverse Allen test. This test is performed by simultaneously occluding both the radial and ulnar arteries until no pulse signal is detected with a pulse oximeter placed on the index finger. The pressure on the radial artery is then released and reappearance of the pulse signal on the oximeter is documented-signifying antegrade flow in the radial artery. This test is not associated with any reported complications or morbidity. Radial artery flow will be studied with Doppler ultrasound. The ultrasound test will be performed by Dr Salim Adawi at no cost. The ultrasound test is a routine non-invasive study which is not associated with any reported complications or morbidity. Clinical and procedural data will be collected in the CRF form in order to characterize risk factors for radial artery occlusion.

Endpoints:

  1. Normal reverse Allen test.
  2. Antegrade flow in the radial artery by ultrasound.

Number of participants:

The Lady Davis Carmel Medical Center catheterization laboratory database will be scanned in order to identify all patients who have undergone transradial catheterization with a 7F sheath. Two-hundred patients, both men and women, will be recruited to the study.

Inclusion and exclusion criteria:

Two-hundred Hebrew-speaking subjects (male and female) who have previously undergone 7F transradial cardiac catheterization at the Lady Davis Carmel Medical Center between 1999 and 2012 will be contacted. Upon giving informed consent they will be recruited to the study.

Statistical analysis Univariate and multivariate analysis will be performed in order to identify demographic, clinical and procedural characteristics that are associated with radial artery occlusion.

References

  1. Amoroso et al. Transradial access for primary percutaneous coronary intervention: the next standard of care? Heart 2010;96:1341-1344.
  2. Freestone et al. Transradial cardiac procedures: The state of the art. Heart 2010;96:883-891.
  3. Bertrand et al. Transradial Approach for Coronary Angiography and Interventions: Results of the First International Transradial Practice Survey. JACC Intv. 2010;3;1022-1031.
  4. Pancholy et al. Effect of Duration of Hemostatic Compression on Radial Artery Occlusion After Transradial Access. CCI 2012;79:78-81.
  5. Uhlemann et al. The Leipzig Prospective Vascular Ultrasound Registry in Radial Artery Catheterization. JACC Intv 2012;5:36-43.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Haifa, Israel, 34362
        • Carmel Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Two-hundred subjects who have previously undergone transradial cathetrization between the years 1999 and 2012 with a 7F sheath will be identified in the Lady Davis Carmel Medical Center Catheterization laboratory computerized database.

Description

Inclusion Criteria:

  • Previous transradial catheterization with a 7F vascular sheath

Exclusion Criteria:

  • Inability to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Study cohort
Cohort of patients who have previously undergone transradial catheterization with the use of a 7F vascular sheath

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Normal reverse Allen test
Time Frame: Within 2 years of the initial procedure
Radial artery patency will be studied with the reverse Allen test. This test is performed by simultaneously occluding both the radial and ulnar arteries until no pulse signal is detected with a pulse oximeter placed on the index finger. The pressure on the radial artery is then released and reappearance of the pulse signal on the oximeter is documented-signifying antegrade flow in the radial artery. This test is not associated with any reported complications or morbidity.
Within 2 years of the initial procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antegrade flow in the radial artery by ultrasound
Time Frame: Within 2 years of the initial procedure
Radial artery flow will be studied with Doppler ultrasound
Within 2 years of the initial procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ronen Jaffe, MD, Carmel Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Anticipated)

July 1, 2014

Study Completion (Anticipated)

January 1, 2015

Study Registration Dates

First Submitted

December 18, 2012

First Submitted That Met QC Criteria

December 18, 2012

First Posted (Estimate)

December 20, 2012

Study Record Updates

Last Update Posted (Estimate)

December 27, 2012

Last Update Submitted That Met QC Criteria

December 26, 2012

Last Verified

December 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • CMC-12-0016 CTIL

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Catheterization

Subscribe